D&A Pharma
Industry
- Pharmaceuticals
Other Names/Subsidiaries
- D&A Pharma SAS
See more in Biomedtracker
Latest on D&A Pharma
Pink Sheet
• By Neena Brizmohun
There is expected to be activity at the European Medicines Agency this week regarding the re-evaluation of PharmaMar’s EU marketing application for Aplidin (plitidepsin), which was rejected in 2018 in
Pink Sheet
• By Lisa Takagi
The European approval process for Eisai Co., Ltd. / Biogen, Inc. ’s Alzheimer’s disease drug Leqembi (lecanemab) has been delayed due to the unprecedented impact from a recent court ruling related to
Scrip
• By Lisa Takagi
In a first, the European approval process for Eisai Co., Ltd. / Biogen, Inc. ’s Alzheimer’s disease drug Leqembi (lecanemab) has been delayed due to a recent court ruling related to the European Medi